Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · June 18, 2015

Longer Duration of FOLFOX Chemotherapy Does Not Improve Survival in Colon Cancer

Clinical Colorectal Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Colorectal Cancer
Impact of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage 3 Colon Cancer
Clin Colorectal Cancer 2015 Jun 05;[EPub Ahead of Print], A Kumar, RD. Peixoto, HF Kennecke, DJ Renouf, HJ Lim, S Gill, C Speers, WY Cheung

Further Reading